Drug
Tolcapone clinical trials
Also written Tasmar.
- studies test it
- 26
- open now
- 1
- in phase 3
- 1
- first study started
- 2001
Keep track of what changes. Save the Tolcapone studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
26 studies that test it; most in 2008 (3)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 2 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 3
- Phase 1
- 6
- Phase 2
- 14
- Phase 3
- 1
- Phase 4
- 2
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 24
University of Chicago (3) · University of California, Berkeley (2) · University of California, San Francisco (2) · University of Pennsylvania (2) · Sheppard Pratt Health System (2) · University of Colorado, Denver (1) · Rutgers, The State University of New Jersey (1) · VA Office of Research and Development (1)
Often tested with
Tested in the same studies.
Duloxetine (1) · Levodopa (1) · Carbidopa (1) · Entacapone (1) · Oxaliplatin (1) · Bromocriptine (1)
Studies
Open first, then newest update. How each study uses Tolcapone is read from its arms, and is right about nine times in ten.
Testing it · 26
- Evaluation of Tolcapone as a Cognitive Enhancer in SchizophreniaRecruitingPhase 2Clinica Universidad de Navarra, Universidad de NavarraNCT06387771Written as Tolcapone
- A Clinical Trial of Tolcapone in Obsessive Compulsive DisorderCompletedPhase 2University of ChicagoNCT05624528Written as Tolcapone
- COMT Inhibition Among Individuals With Comorbid AUD/ADHDCompletedPhase 2University of Colorado, DenverNCT03904498Written as Tolcapone
- Microbiome Derived Metabolism and PharmacokineticsCompletedPhase 1Rutgers, The State University of New JerseyNCT05065671Written as Tolcapone 100 MG
- Remediation of Impaired Self-Regulation in Patients With Mild TBICompletedEarly Phase 1VA Office of Research and DevelopmentNCT02260570Written as Tolcapone
- Effects of Tolcapone on Frontotemporal DementiaCompletedPhase 2Columbia UniversityNCT00604591Written as Tolcapone
- Trial of Tolcapone With Oxaliplatin for NeuroblastomaTerminatedPhase 1Giselle ShollerNCT02630043Written as Tolcapone
- Dopaminergic Mechanisms Underlying Human Social BehaviorCompletedEarly Phase 1University of California, BerkeleyNCT04205994Written as Tolcapone 200 MG
- Effects of Cortical Dopamine Regulation on Drinking, Craving, and Cognitive ControlCompletedPhase 2Medical University of South CarolinaNCT02949934Written as Tolcapone
- Tolcapone Treatment of Pathological GamblingCompletedPhase 2University of ChicagoNCT00927563Written as Tolcapone
- Tolcapone in Obsessive Compulsive DisorderCompletedPhase 2/3University of ChicagoNCT03348930Written as Tolcapone 200 MG
- Dopaminergic Modulation of Frontostriatal Function With a Dopamine Agonist and COMT InhibitorWithdrawnPhase 4University of California, BerkeleyNCT02929485Written as Tolcapone
- Dopamine Responsivity in GamblersCompletedNot applicableUniversity of California, San FranciscoNCT02772978Written as Tolcapone
- A Study of Neural Circuit Responses to Catechol-O-methyl Transferase (COMT) InhibitorsCompletedNot applicableUniversity of California, San FranciscoNCT01158950Written as Tolcapone
- Effects of Tolcapone on Decision Making and Alcohol Intake in Alcohol UsersCompletedPhase 2Jennifer MitchellNCT02740582Written as Tolcapone
- Short-term Effects of TOLCAPONE on Transthyretin Stability in Subjects With Leptomeningeal TTR Amyloidosis (ATTR)CompletedEarly Phase 1Boston UniversityNCT03591757Written as Tolcapone
- A Study Assessing the Safety and Pharmacokinetic Profile of Modified Release Formulations of TolcaponeCompletedPhase 1Corino Therapeutics, Inc.NCT03633591Written as Tolcapone
- Clinical Trial of Tolcapone for Cognition in SchizophreniaTerminatedPhase 2National Institute of Mental Health (NIMH)NCT00044083Written as Tolcapone
- Pilot Study of Tolcapone in SmokersCompletedPhase 2University of PennsylvaniaNCT01202955Written as Tolcapone
- A Trial Evaluating Effects of COMT Inhibition in Patients With Acquired Brain InjuryStatus unknownPhase 2Sheppard Pratt Health SystemNCT03273062Written as Tolcapone 200 MG
Codes
What other systems call Tolcapone · ClinicalTrials.gg INT006812
- MeSH (NLM) D000077867TolcaponeConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) CIF6334OLYTOLCAPONEConfirmed FDA, NLM, Wikidata
- RxNorm 72937Confirmed FDA, Wikidata
- Wikidata Q413840tolcaponeConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47762TolcaponeOne source FDA
- DrugBank DB00323One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077867 | Tolcapone | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | CIF6334OLY | TOLCAPONE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 72937 | — | Confirmed FDA, Wikidata |
| Wikidata | Q413840 | tolcapone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47762 | Tolcapone | One source FDA |
| DrugBank | DB00323 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.